INTRODUCTION
The Mayak Production Association (MPA) in Ozyorsk, Russia, was the first facility for the production of weapons-grade plutonium in the former Soviet Union. Unfortunately, many workers were exposed to relatively high amounts of plutonium, particularly in the early years of operation (1) . The United States and Russian governments established a bilateral agreement, the Joint Coordinating Committee for Radiation Effects Research (JCCRER) to study the MPA workers to better understand the human radiobiology and toxicity of plutonium and related alpha-emitting isotopes (2, 3) . One of the objectives of the research conducted under the JCCRER is to better understand the biokinetics and dosimetry of plutonium in the human such that better risk models may be developed.
The Southern Urals Biophysics Institute (SUBI) in Ozyorsk, Russia, has been collecting data and performing studies of the MPA workers since the early 1950s. The current MPA worker cohort contains employment, occupational, health and dosimetry records on over 26 000 workers. Work conducted at SUBI over the years includes radiochemical measurements and associated data on autopsy samples from 1250 deceased MPA workers.
Most occupational exposures to plutonium are through the inhalation of plutonium-containing aerosols, although other pathways of exposures can occur, such as penetrating wounds. When plutonium aerosols are inhaled, some of the plutonium will leave the lungs and enter the systemic circulation and deposit primarily in the liver and skeleton (4, 5) . In early years after exposure (about 1-10 years), the relative amounts of total systemic (non-pulmonary) plutonium found in the skeleton and liver of 'healthy' workers were about 43 and 45%, respectively (4) . In later years after exposure, some studies report a gradual shift towards a greater relative skeletal distribution (5) . It is necessary to estimate the total plutonium skeletal burden, as well as the burden in other organs, to develop biokinetic and associated risk models for humans. In the case of the MPA workers, only limited skeletal autopsy samples have been available and thus methods, described here, were developed to estimate total skeleton burden from limited skeletal samples. Because plutonium and other actinides are not uniformly distributed among bones or even within individual bones (6, 7) , the bone composition, specifically the relative amounts of cancellous and cortical bone, and the anatomical location of the bone sample must be considered (8, 9) . Some prior studies have developed methods for estimating total skeletal burdens of actinides based on limited samples, but the method is dependent on the samples that are available (10, 11) . In the present study, a method was developed to estimate total skeletal body burdens of plutonium in the MPA workers from limited sample sets. This approach was developed and validated using comparative data from total body donation cases from the United States Transuranium and Uranium Registries (USTUR) (12, 13) .
MATERIALS AND METHODS

Mayak worker autopsy materials
Radiochemical measurements of tissue samples and associated information for 1250 autopsy cases of MPA workers who died from 1955 to 2013 were obtained from a database maintained at SUBI. For estimating the total skeletal burden of plutonium, different autopsy protocols were employed over this period of time. Specifically, from 1955-1995, six to nine skeletal samples were collected at autopsy. There were 88 MPA worker autopsy cases where all nine bone samples were available and these included: occipital and temporal skull bones, thoracic and lumbar vertebrae, rib, ilium, and epiphysis, metaphysis and diaphysis of the femur. However, not all of these samples were available for each worker. In more recent years (after 1995) only one or two bone samples were available, usually a lumbar vertebra and/or rib. In each individual case, the total wet weight of the bones ranged from 200 to 400 g (average of 280 ± 40 g) and the mass of the bone ash ranged from 20 to 100 g (average of 60 ± 40 g). The worker profiles for 88 MPA autopsy cases are summarized in Table 1 .
Radiochemical analysis
Methods to measure plutonium evolved over the more than half century that samples from the MPA workers have been collected and analyzed. A summary of the alpha-radiometry and alphaspectrometry methods used from 1955 to the present are presented in Table 2 , details on some of these methods have been previously published (4, (14) (15) (16) . In all cases, bone samples were ashed at 450-500°C, weighed, and dissolved in mineral acid. Plutonium was separated and purified from acid-digested tissue samples using anion-exchange techniques. Pu) in 0.5 g of bone ash was measured using alpharadiometry. From 1955 to 1967, a high-background alpha-radiometer with a measurement efficiency of about 40% was used. From 1968 to 2000 a lowbackground alpha-radiometer using a scintillation method (ZnS) with a registration detection efficiency of 0.95 ± 0.00 was used. The decision threshold (DT) for the measurement of plutonium decreased over time ( Table 2 ). The DT levels provided estimates of plutonium activity concentrations to 0.31 Bq g −1 bone ash during the early years and down to 0.016 Bq g −1 of ash in the later years.
Alpha-spectrometry has been used since 2001 for the measurement of 238 Pu and 239,240 Pu in 1-3 g of bone ash (17) . The use of alpha-spectrometry greatly improved measurement capabilities for plutonium in bone compared with alpha-radiometric methods (summarized in Table 2 ). Using alpha-spectrometry, the DT level for 239, 240 Pu was about 2.8 × 10 −3 Bq with the lowest limit of detection of plutonium activity concentration of about 1.42 × 10 −3 Bq g −1 of ash with an error of ±60%.
Appendix 1 contains details regarding the relative standard deviation (RSD x ) of each radiochemical method.
Bone samples from the MPA workers
The most complete subset of bones obtained from the MPA workers included nine samples: occipital and temporal skull bones, thoracic and lumbar vertebrae, rib, ilium, and epiphysis, metaphysis and diaphysis of the femur. Because these samples were obtained from different bones and different regions within a bone, each bone type differed in their relative composition of cortical and cancellous (trabecular) bone (18) and (18) . These anatomical compartments reflect the entire skeleton and included the 'cranium', 'vertebral column', 'ribs' (which included the clavicle, sternum, and scapula), 'ends of the long bones' (epiphysis and metaphysis), 'shafts of the long bones' (diaphysis), and the 'pelvic bones' ( Table 3) .
The total ash mass of the skeleton was assumed to depend on the total body mass (19) . In about 70% of the MPA autopsy cases, the in-life total body mass and body height of the individuals were determined from medical records. There was a wide range of body mass from 45 to 125 kg for males and 40 to 120 kg for females. Body heights ranged from 150 to 195 cm and 150 to 172 cm for males and females, respectively. Larger variations in body weights were often associated with late-in-life chronic diseases. When differences greater than 15% were found between an individual's body weight and those for Reference Man values (18, 19) , a correction was applied (Corrected Body Mass, as described below). When information on total body mass and height was not available, the data from Reference Man (19) was used for calculating plutonium skeleton burdens in the MPA workers ( Table 4) .
Estimation of total skeletal plutonium burden for the MPA workers from limited skeletal samples
The total burden of skeletal plutonium in the MPA workers was estimated by extrapolating the concentrations measured in the limited bone ash samples to the entire skeleton ash. This was done assuming a Table 3 . Bone samples from 88 MPA workers that comprised the skeletal compartments. The cortical and cancellous bone fractions were taken from Reference Man (19) , where the ribs were combined with the clavicle, sternum and scapula.
Skeletal compartment
Bone sample MPA Ash fraction (Mean ± SD)
Bone composition (%) (19) Cortical bone ratio of the ash mass to the total skeletal weight with adjustments for age and sex. The type and composition of the individual bones were also considered, as discussed above. Because the number of available bone samples varied for the individual MPA workers, two algorithms were developed to calculate the skeletal plutonium burden; one for cases where six to nine bones ('Large' Sample set) were available representing all six skeletal compartments (Table 3 ) and the other when one to five bones ('Small' Sample set) were available. For the Small Sample set the distribution factors for the six skeletal compartments were derived and used to estimate skeletal plutonium burden. The 88 MPA worker autopsy cases, where all nine bone samples were available, were used to calculate the deposition factors (K dep i ) for plutonium that were used in the Small Set algorithm.
Bone samples from USTUR cases
It was first necessary to validate the total ash skeleton weight for each of the MPA workers from limited samples. The algorithm that was developed to estimate skeletal ash fraction values for the MPA samples was applied to bone ash and wet mass data for all bones in the skeleton from 12 whole-body donation cases from the USTUR. With the exception of cases 0720 and 0769, the other 10 cases have been described previously (8, 20, 17, (21) (22) (23) (24) . The USTUR data on plutonium concentrations in bones of 12 donors were also used to validate the MPA algorithms for skeletal burden estimation on limited bone samples. The characteristics of the 12 USTUR cases are summarized in Table 5 .
Details of the USTUR case bone mass characteristics are summarized in Table 6 .
Uncertainties of plutonium skeleton burden
Estimation of plutonium skeleton burden is a function of several variables, each with their own inherent uncertainties. These variables include average nuclide concentration in skeletal part i, C i , weighting factors, η i , and deposition coefficients in skeletal compartments, K dep i and uncertainties of skeletal weight (ash) estimation, M b (or M ash ). Therefore, to determine standard deviation or relative standard deviation of plutonium skeleton burden, the classical method of uncertainty propagation, ISO 11929:2010 (25) , was used. To calculate uncertainty, the following symbols have been introduced:
x is the standard deviation of estimated value x, RSD (x) is the corresponding relative standard deviation of the value x.
Uncertainties in skeletal weight estimation were not investigated in this study. As detailed in above, the bones were included in six groups (i.e. skull, vertebral column, ribs, ends of long bones, shafts of long bones and pelvic bones) with a maximum of nine samples included in these six groups. The average plutonium concentration in ith skeleton compartment,C i , and corresponding standard deviation σ (¯) C i are determined as follows:
where C i,j is the radionuclide concentration in the ash of a j-bone sample of the ith skeleton compartment and k is the number of bone samples for ith skeleton compartment.
are the standard deviation and relative standard deviation of the radionuclide concentration in the ash sample of the j-bone of the ith skeleton compartment, respectively.
The form of the equations for the standard uncertainty of results of concentration measurement is determined by the measurement method, specifically alpha-radiometry and alpha-spectrometry (see Appendix 1). Table 4 . Reference values for total body mass, lung, liver and wet skeletal mass, kg, and as a percent of total body mass (%) and for skeletal ash as a percent of wet skeletal weight (%) (19) . Relative standard deviation of plutonium skeleton burden for the Large Set
In case of a Large Set of bones (6-9 samples) the total nuclide burden in the skeleton as determined using equation (1) then considering bone mass, and a corresponding equation for relative standard deviation as follows:
where Q sk is the total skeleton burden of plutonium in Bq (see detail in equation (6)); Q i is the plutonium burden in ith skeletal compartment in Bq,
(see detail of mass estimation in equations (6, 7)) and n is the number of skeleton compartments, n = 6.
whereC i is the average nuclide concentration in bones of the ith skeletal compartment, Bq g −1 ash; η i is the mean value (derivation described below) accounting for the fraction of all ashed bones of the ith skeletal compartment of total ash mass of the whole skeleton based on data for the USTUR donors (Table 6 ).
Relative standard deviations of plutonium skeleton burden for the Small Set
In case of a Small Set of bone samples (<6), the total nuclide burden in skeleton as determined by Whole skeleton 2888 ± 364.9 0.296 ± 0.032 1 a As indicated in Table 3 , samples also taken at autopsy from the MPA workers.
equation (3) and a corresponding relative standard deviation was as follows: where K dep, i is the fraction of plutonium deposition in ith skeleton compartment (see equation (15)).
Statistical methods
The data are expressed as arithmetic mean ± standard deviation (SD). Differences between the mean ash values obtained for bones from the MPA cases (Table 3) and from the USTUR donors (Table 6) were tested for significance using a two-sided Students t-test. Two group comparisons of the plutonium skeleton deposition coefficients (K dep i ) for the MPA cases with and without liver pathology and for the MPA cases and the USTUR cases (Table 7) were done using a Mann-Whitney U-test. Differences were considered significant when the p-value was <0.05.
RESULTS
Estimating the MPA plutonium burden in the skeleton developed for the Large Set
For the Large Set (six to nine bone samples) cases, the plutonium burden in the skeleton, Q sk , was calculated by equation (3) as the sum of the nuclide burdens estimated for the six anatomical compartments ( Table 6 ) that represented the entire skeleton. The portion of the total skeletal plutonium activity contributed by the ith skeletal compartment, Q i , was estimated by the average nuclide concentration in the ash,C i , and the fraction of the ash mass of all bones of the ith skeletal compartment of the ash mass of the entire skeleton, η i .
Additionally considering the wet and ash weights of the samples and the worker body mass, the following equation was used to calculate the skeleton burden of plutonium Q sk : where M b (CBM)·ξ wet ·0.29 = M ash is the ash weight of the skeleton for male or female, g; where: M b is the actual body mass while alive, g; CBM is the corrected body mass, used in cases where the total body weight was greater or less than 15% of Reference Man (derivation described below), g; ξ wet is the coefficient accounting for the skeleton fresh wet mass fraction of the total body mass for males (0.144) and females (0.13) from Reference Man (19) ; 0.29 is the ash mass fraction of the skeleton mass for Reference Man (male and female) (19) . η i andC i were defined above (equation (4)).
The factor η i determination
The average factor η i value accounting for the fraction of ash of all bones of the ith skeleton compartment of the total skeleton ash mass was calculated using data for the USTUR donors as:
where m ash i, j is the ash mass of all bones of the ith skeletal compartment of j-donor, g and M ash is the total ash mass of the whole skeleton of j-donor, g. Table 7 . Comparison of plutonium deposition coefficient, K dep , in the skeleton compartments for the MPA cases with and without liver pathology and that for the USTUR cases (Mean±SD). The ash fraction value as the ash mass (g)/wet mass (g) ratio was determined for all bones in the skeleton of 12 USTUR whole-body donation cases (Table 5) . Then, those bones that had values close to the ash fraction values measured in the MPA cases were distributed into the six skeletal compartments considering the anatomical and morphological features of the bones. After that, for each ith skeletal compartment the value η i as the fraction of ash of all bones of this skeleton compartment of ash mass of the whole skeleton was determined. Table 6 provides the results of grouping of all bones of the USTUR donors into six skeletal compartments and gives mean values of ash weighting factor of η i as the fraction of bone ash of the ith skeleton compartment of total ash mass of the whole skeleton. The mean ash fraction values for bones from the USTUR donors did not statistically differ from those from the MPA cases (Table 3) . Thus, it was assumed that the ash content values for all other unmeasured bones in the MPA cases would correspond to the ash content obtained for those bones in the USTUR cases.
Skeletal compartment
K dep i , MPA, total α-Pu K dep i , USTUR,
Corrected body mass (CBM) determination
The total ash weight of the skeleton used to estimate the plutonium burden was assumed to depend on the total body mass (18, 19) . As noted above, there was a considerable range in the body mass among the MPA cases. When the recorded body mass differences were greater or less than 15% of those in Reference Man (18) , a correction factor was applied. The correction factor was based on the ICRP concept that body mass can be viewed as consisting of two compartments: Lean body mass (LBM) and nonessential fat (NF) (18) . The LBM includes essential body fat and is a function of the actual height (length, L) of the individual:
2.04 10 L in cm for Reference male, and 8
for Reference female. 9 3 2 The typical relationship of body fat to total weight for different ages was used as described in Reference Man (18) . For example, from ages 25 to 45 years for a 70 kg male, the body fat was 15-18%, but 25-30% for a 100 kg male. The Reference Man updated by the ICRP in 2002 (19) , assumed a 73 kg male had 20% total body fat and a 60 kg female had 30% body fat, specifically: Using equations (8) and (9), and the solutions of equations (10) and (11) result in the following relationship with body height that was used to determine the Corrected body mass (CBM) for overweight or underweight Mayak workers:
2.55 10 , L in cm for males, and 12
2.50 10 , L in cm for females 13 3 2 Estimating the MPA plutonium burden in the skeleton using Small Set
In about 40% of the 1250 MPA autopsy cases, five or fewer bone samples were available. Furthermore, in recent years, 2009-2012, estimates of total skeletal plutonium burdens were obtained from only 1-2 samples (about 5% of the total cases presented here).
For these situations where 1-5 samples were collected, the calculation method used the deposition coefficients, К dep i, as fraction of plutonium activity in i-skeletal compartment of total skeletal burden. The K dep i values were obtained from the data from the 88 MPA cases where larger bone sample set was available (Table 4) . Following the form of equation (6) was used to estimate the skeletal burden in cases of Small Set (from one to five samples):
where∑К dep i is the sum of deposition coefficients for plutonium measured in n-skeletal compartments (n = 1−5). Other terms of the equation were defined above (see equation (6) .
Determination of the plutonium deposition coefficient,
Plutonium burden in the skeleton for the 88 MPA cases that had nine bone samples was calculated using the ash fraction value grouping, according to equation (6) .The fractions of plutonium deposition in the six skeleton compartments, К dep i (Table 7) , were calculated as the plutonium burden in the ith skeletal compartment Q i divided by the total skeletal plutonium burden Q sk :
Possible influence of liver pathology on K dep i
It was previously reported that liver chronic diseases resulted in a significant distribution of systemic plutonium from the liver to the skeleton (5) . While liver diseases may result in a redistribution of plutonium between the liver and skeleton, the data from the present study indicated that liver diseases had little substantive effect on the distribution of plutonium within the skeleton compartments. From Table 7 , the fractions of plutonium deposition in skeletal compartments, K dep i , obtained for the MPA cases without liver pathology compared with those with liver pathology did not differ statistically using a MannWhitney U-test (p > 0.05). When the arithmetical mean values of K dep i for the MPA cases were compared with those of USTUR cases a significant difference was only noted with the pelvic bone compartment ( Table 7) .
Validation of deposition coefficients, K dep,i
The deposition coefficients, K dep,i , were verified based on a random sampling from 176 MPA cases. For these cases, the period of exposure was between 1948 and 1993, an average duration of work was 17 ± 10 years, and the plutonium body burden ranged from 1 to 120 kBq. A set of bones in cases selected included six samples: occipital bone, thoracic or lumbar vertebra, rib, and the epiphysis, metaphysis and diaphysis shaft of the femur. An ilium sample was not available. The calculations of plutonium skeleton burdens were carried out according to equation (14) for two scenarios: the plutonium concentrations were available for all six bones (Q sk 6 ) and when concentrations were only measured in two bone samples: lumbar vertebra and rib (Q sk 2 ). To calculate the plutonium burden in the skeleton for bone sets, Q sk 6 and Q sk 2 , the K dep i for the MPA cases from Table 7 were used: ∑K dep = 0.907 for six bones and ∑K dep = 0.337 for two bones. Figure 1 illustrates the correlation between individual estimates of the plutonium burden in the skeleton obtained for 176 autopsy cases using different values of deposition coefficients, K dep i for cases with six bone samples (Q sk 6 ) or two bone samples (Q sk 2 ). The plutonium burdens in the skeleton for these two sets of bone samples calculated from equation (14) were very similar and the Q sk 2 /Q sk 6 ratio was equal to 1.04 ± 0.27. The correlation coefficients of R = 0.96 Thus, the deposition coefficients (K dep i ) used in the calculations of the plutonium burden in the skeleton in cases with different numbers of bone Figure 1 . Correlation of individual estimates of the total MPA worker plutonium skeletal burden (Bq) calculated from two sets of bone samples: Q2 for a set of two bone samples, Q6 for a set of six bone samples.
samples, from 1 to 6, yielded reasonably consistent results.
The results of radiochemical analyses of all bones in the USTUR cases provide an opportunity to derive mathematical correlations between measured and estimated values of the plutonium burden in the skeleton. Data from individual bones in the USTUR cases were used to validate the method of extrapolating the data on the plutonium content from the limited bone sample sets to the plutonium content in the entire skeleton for the MPA cases. When the plutonium (primary plutonium) contents were measured in nine bones in the MPA cases (Table 3) , the calculations were performed using equation (6) . When the plutonium contents were only available for two bones in the MPA cases (rib and lumbar vertebra), the calculations were carried out using equation (14) and the correction factors, К dep i , for those skeletal compartments from Table 7 .
The skeleton plutonium burdens were then calculated in the USTUR cases using Large (equation (6)) and Small (equation (14)) sample sets and then compared to the measured values for these cases. The calculated/measured ratios for total plutonium skeletal burdens ranged from 1.0 to 1.4 with a mean of 1.2 ± 0.2 in the larger sample set and from 1.0 to 2.3 with a mean of 1.4 ± 0.4 for the smaller set. A small discrepancy of mean values of ratios was probably due to different measurement methods for the plutonium concentrations used in the MPA cases and in the USTUR cases. In the MPA cases the plutonium concentration ( 238 Pu + 239,240 Pu) in bones was measured using alpha-radiometry, in the USTUR cases the 239,240 Pu concentration was measured by alpha-spectrometry. When the calculated skeletal activity (from the USTUR data) was plotted against the measured skeletal activity (from SUBI data), a good correlation was found with correlation coefficients of about R = 0.98 for both sample sets (Figure 2) . Figure 2 illustrates that SUBI values are above 1-to-1 line; the SUBI algorithm overstates real USTUR values, on the average by 20% (Q 6 ) or 40% (Q 2 ). For conservative estimation, such overestimation of the plutonium skeleton content is quite acceptable.
Uncertainties in the estimation of plutonium skeleton burden
When calculating the relative standard deviation in the measurement of activity in a bone sample, RSD (A sample ), and the skeletal burden, RSD(Q sk ), the characteristics of the alpha-radiometric and alphaspectrometric methods of plutonium measurements were used ( Table 2) .
The calculations of RSD(x) in Table 8 show that the accuracy of determining skeleton burden, Q sk , largely depends on the number of bone samples used. It is natural to assume that the uncertainty decreases as the number of samples increases. The calculations of RSD(Q sk ) for two sets of bones were performed: nine samples and two samples (vertebra and rib) on condition that the measured activities in bone samples correspond to DT values (Bq) for the measurement methods. Table 8 shows the values of the relative standard deviation in the estimation of nuclide skeleton burden, RSD(Q sk ), obtained for two methods of measuring the nuclide activity in bones at the DT level.
The dependence of RSD(Q sk ) on the number of bones measured is evident in Figure 3 , where the values of the relative deviation obtained for the larger and smaller sets of bones using alpha-radiometry and alpha-spectrometry (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) are given. For example, during the early period, 1955-1967, where alpha-radiometry was used, the maximum relative standard deviation, RSD(Q sk ), is equal to about 63% for a set of two bones while the value for 9 samples was about 31%.
In the later period from 1983 to 2013, improvements in measurement efficiencies resulted, as expected, in decreases in the uncertainties. During this period, the relative deviations remained fairly constant regardless of the measurement method. When the later sample sets (6-9 samples) were measured, the values obtained in case of measuring a complete set of samples (6-9 samples) were notable for a low uncertainty: the values of the relative standard deviation, RSD(Q sk ), did not practically differ for the two measurement methods and did not exceed 24% for 239, 240 Pu measured by alphaspectrometry (Figure 3a) . In the cases where only two bone samples were measured, the relative standard deviations of the plutonium skeleton burden, RSD(Q sk ), amounted to about 50% for alpharadiometry and alpha-spectrometry (Figure 3b) .
Higher values of the relative standard deviation for 238 Pu as compared to corresponding values for 239,240 Pu, when using alpha-spectrometry, are explained by lower DT values for 238 Pu. As follows from Table 2 , DT values differ by about an order or magnitude: DT( 238 Pu) = 0.18×10 −3 , DT ( 239,240 Pu) = 2.83×10 −3 . According to the equations (A.2) and (A.3) of Appendix 1, when applying alpha-spectrometry, one term of the equation for the uncertainty, particularly RSD 1 which contributes the most significantly to the estimation of the relative standard deviation in the measurement of activity in an aliquot, RSD(A a ), is inversely proportional to DT value.
DISCUSSION
This article describes the methods that have been and continue to be used by investigators at SUBI to estimate the plutonium skeletal burdens in autopsy cases of former MPA workers. The same methods used for limited bone samples from the MPA autopsy cases were validated with data for samples of whole body donation cases from the USTUR. For most USTUR cases, the calculated m ash i,,j and K depj,j values are shown to be similar. The methods described here to estimate total skeletal plutonium burden from limited sets of bone samples from the MPA workers had an excellent correlation when these same methods were used and compared with results from total body donation cases from the USTUR. These studies provide an experimental foundation for the use of limited skeletal samples to estimate total skeleton plutonium burdens. These data can be used for the development of biokinetic and associated radiation-risk models in humans.
Various studies in the past used individual bones or parts of bones to estimate total skeletal and body actinide burdens. This is a reasonable approach since measuring plutonium and/or other radionuclides in the entire skeleton would be challenging. However, the whole body donor studies from the USTUR (reviewed by Kathren (26) ) have provided much of the basis for extrapolating results from individual bones, such as was done in this study, to whole skeleton burdens. Lynch et al. (10) described the detailed skeletal distribution of plutonium and/or americium from three human half-skeletons. Later Filipy et al. (11) used data from eight whole body cases to derive equations to predict skeletal concentrations based on limited bone samples. In recent years other investigators have used related approaches to those used in this study. For example, individual vertebra from autopsy cases were used to predict skeletal half-times of plutonium and strontium in the Swiss population (27) and samples of bone obtained during joint replacement surgery have been proposed as a tool to assess body burdens of bone-depositing nuclides, plutonium, americium and strontium in human populations (28) . Chronic or late-in-life diseases, particularly those that involve the liver (i.e. primary and secondary cancers, cirrhosis, fatty degeneration) are known to cause a redistribution of plutonium from the liver to the skeleton, also while increasing excretion. For example, in 'healthy' workers, the relative fractions of the total systemic (non-pulmonary) plutonium were found to be about 47% in the liver and 45% in the skeleton (4) . However, when liver disease was present there was a dramatic shift in these fractions with about 15% found in the liver and 75% in the skeleton (5) . In the present study, the fractions of plutonium in the skeletal parts were determined and compared in cases with and without liver disease with those of the USTUR bones and were found to be not statistically different with the exception of the pelvis. Animal studies would suggest that redistribution of plutonium from the liver to the skeleton would favor more highly vascularized trabecular bone sites over cortical bone sites (6, 29, 7) However, further studies would be needed to confirm these findings in humans with liver disease, but at present, no adjustments are indicated in the current methods to estimate total plutonium burden from limited bone samples. In the future, however, adjustments in biokinetic, dosimetry, and risk models may be made in cases where late-in-life diseases may have altered the organ distribution of plutonium.
There are a number of possible uncertainties associated with the derivation of whole body plutonium concentrations derived from limited bone samples as described in this paper. Some of the uncertainties include those associated with the different measurement techniques used over the years, the number of bone samples and the concentrations of plutonium in the individual bone samples. As measurement techniques changed and improved over the years, from alpha-radiometry used from the mid-1950s to 2000 to alpha-spectrometry that has been in use to the present (Table 2) , measurement uncertainties have been reduced. Additionally, the number of available bone samples (i.e. two vs. nine) is also an important determinant of the measurement uncertainty. Using a relative standard deviation calculation, the uncertainties associated with the measurement of nine bone samples were estimated to be about half of that when only two bone samples were available ( Figure 3 ). Another possible source of uncertainty is the effect of health status, specifically late in life diseases that may have altered plutonium distribution between the liver and the skeleton. Future studies will continue to identify sources of uncertainty in organ burdens and explore ways to reduce these uncertainties.
In summary, the method that is used to estimate skeleton burdens of plutonium from limited bone samples obtained at autopsy of former MPA workers is described. The method was developed and validated with whole body donation cases from the USTUR and very good correlation was noted. For conservative estimation, developed algorithms overestimate measured USTUR values, on average by 20% (Q 6 ) or 40% (Q 2 ). As additional data are collected and the approaches and methods improved, uncertainties in the current method should be reduced. The current data are being used to develop and update biokinetic, dosimetric and risk models of actinide exposures in humans.
